Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications. - Wikidata - awgldk - TriplyDB

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

http://www.wikidata.org/entity/Q33770499

about

Demographics, treatment regimens and the use of angiotensin-receptor blockers in heart failure: findings from the Valsartan Heart Failure Trial.Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets.Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients.Cell Type-Specific Mechanisms in the Pathogenesis of Ischemic Stroke: The Role of Apoptosis Signal-Regulating Kinase 1.

P2860

Q35572277-FA2CB2E8-E60A-4C3D-B80E-E4084A9FD5A2 Q36675400-638FBEE8-5D39-4003-888E-6DE6AA982E6E Q44090042-C4FA5D91-1C34-47CD-BAC0-C6E7E7224E07 Q44122688-C359DF72-9C05-4579-8CFE-1BD087AB4DA1 Q54111091-91115A4F-B3EB-4B59-9F92-A259D68D9441

P2860

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

http://www.wikidata.org/entity/Q33770499

description

1999 nî lūn-bûn

@nan

1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

@ast

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

@en

type

label

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

@ast

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

@en

prefLabel

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

@ast

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

@en

P1433

Q33770499-43220491-6D23-4E5D-8B22-91B673482D45

P1476

Q33770499-8282F90B-0691-4C01-84BA-BD76A1E852D5

P2093

Q33770499-67A89998-4B62-4AA4-903A-4F49F27782A0

Q33770499-E435C135-48A4-44B6-A10F-D186748EC0A9

P2860

Q33770499-13007266-46F1-414F-AB07-B77AE52D08BE

Q33770499-15C1AC5F-919C-423F-9A72-F1A0AB3496CE

Q33770499-2082ECBD-9FFF-46AC-A53F-1E717729C391

Q33770499-41D4D166-58B3-4301-B154-FFC36C50DD7F

Q33770499-4D721643-D896-47DD-AE49-8F0795956716

Q33770499-5FBAC298-30F2-4C7F-9131-A542679A1E48

Q33770499-788D7866-1DB8-47BD-AC0C-9A0ED26C9FFC

Q33770499-8EFF9D26-146B-4890-8C86-5D32F9898937

Q33770499-A0782BDB-362C-41C8-84D5-2F9B65DF776D

Q33770499-A080745C-243A-47BF-A0DC-C92E2E4CEB81

P304

Q33770499-DD50F419-A958-4979-8E00-422616F74D86

P31

Q33770499-6BED7FEB-6035-41A4-8BCF-4C7793D2161E

P356

Q33770499-A4513124-8B3F-44B1-83D1-9E052F5E1E55

P433

Q33770499-A9B669B1-E1B0-434E-A07E-06F052BCDF02

P478

Q33770499-A4674A01-4F37-4B64-AAD6-3EB806783255

P577

Q33770499-74008D62-92BF-4D1D-9CBC-486FA274A789

P5875

Q33770499-6D3C016A-B1D1-498B-9DD1-39DD58B2FC68

P698

Q33770499-ECB3088A-3740-4E03-8302-5684D8F47584

P921

Q33770499-6BDA6D8B-620C-4DAB-A823-7FB895FBF20D

P932

Q33770499-93CA7691-E38F-4F11-8A37-86E347B50820

P356

P1433

Clinical Cardiology

P1476

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications

@en

P2093

J J Ferguson

http://www.w3.org/2001/XMLSchema#string

J M Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators.

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

Molecular bases of the acute coronary syndromes.

Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.

Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms.

Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.

P304

687-698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.4960221103

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227841113

http://www.w3.org/2001/XMLSchema#string

P698

10554682

http://www.w3.org/2001/XMLSchema#string

P921

P932

6656089

http://www.w3.org/2001/XMLSchema#string